Viracta Therapeutics Inc. Gains 37.35%

Wed, May 17, 2023 at 07:44 PM
Viracta Therapeutics Inc. Gains 37.35%

Viracta Therapeutics Inc. (VIRX:NASDAQ) jumped higher at $1.71, a gain of 37.3%. On Wed, May 17, 2023, VIRX:NASDAQ hit a New 2-Week High of $1.71. The stock got featured on our News Catalysts scanner on Thu, May 11, 2023 at 04:44 PM in the 'MISCELLANEOUS' category. From Wed, May 03, 2023, the stock recorded 60.00% Up Days and 36.36% Green Days

About Viracta Therapeutics Inc. (VIRX:NASDAQ)

Viracta Therapeutics Inc is a clinical-stage, biomarker-directed precision oncology company focused on advancing new medicines for the treatment of virus-associated malignancies.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.